PTX 0.00% 3.9¢ prescient therapeutics limited

Pitt Street Research is run by Stuart Roberts (one of the...

  1. 5,960 Posts.
    lightbulb Created with Sketch. 18458
    Pitt Street Research is run by Stuart Roberts (one of the authors of this report) who is a well-known two-decade veteran of the Australian biotech industry. He previously worked as a biotech analyst at a couple of leading broking firms.

    You pay for coverage by Pitt Street Research. It fills the void in coverage of smaller biotechs by the well-known sell-side analysts.

    A then-unloved Neuren commissioned coverage by Pitt Street Research back in late 2018 for this very reason.

    https://lifesciencessummit.co.nz/speaker/stuart-roberts/
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.